NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM AN OFFER FOR SALE OF, OR THE SOLICITATION OF AN OFFER TO BUY, THE SECURITIES REFERRED TO HEREIN IN ANY JURISDICTION, INCLUDING THE UNITED STATES, CANADA, AUSTRALIA, SOUTH AFRICA, JAPAN OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW.
Vivoryon Therapeutics Successfully Completes Private Placement Raising EUR 25 Million
To access the press release, please click here.
DUBLIN--(BUSINESS WIRE)--The "U.S. Electronic Medical Records (EMR) Market - Focused Insights 2024-2029" report has been…
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 21, 2024) - BioHarvest Sciences Inc. (CSE:…
LEXINGTON, KY / ACCESSWIRE / June 21, 2024 / NX Development Corp. (NXDC) is pleased…
"Healthcare providers often find themselves balancing the demands of patient care with the complexities of…
LAS VEGAS, NV / ACCESSWIRE / June 21, 2024 / Inflation, medical revenue losses, staffing…
KUALA LUMPUR, MALAYSIA / ACCESSWIRE / June 21, 2024 / NASDAQ-listed AGAPE ATP Corporation ("ATPC"),…